Fully bioresorbable vascular scaffolds: lessons learned and future directions
H Jinnouchi, S Torii, A Sakamoto… - Nature Reviews …, 2019 - nature.com
Fully bioresorbable scaffolds (BRS) were designed to overcome the limitations of metallic
drug-eluting stents, which permanently cage the vessel wall, thereby preventing normal …
drug-eluting stents, which permanently cage the vessel wall, thereby preventing normal …
Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures
F Prati, G Guagliumi, GS Mintz, M Costa… - European heart …, 2012 - academic.oup.com
This document is complementary to an Expert Review Document on Optical Coherence
Tomography (OCT) for the study of coronary arteries and atherosclerosis. 1 The goal of this …
Tomography (OCT) for the study of coronary arteries and atherosclerosis. 1 The goal of this …
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions …
PW Serruys, B Chevalier, D Dudek, A Cequier… - The Lancet, 2015 - thelancet.com
Background Despite rapid dissemination of an everolimus-eluting bioresorbable scaffold for
treatment for coronary artery disease, no data from comparisons with its metallic stent …
treatment for coronary artery disease, no data from comparisons with its metallic stent …
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month …
M Haude, H Ince, A Abizaid, R Toelg, PA Lemos… - The Lancet, 2016 - thelancet.com
Background Absorbable scaffolds were designed to overcome the limitations of
conventional, non-absorbable metal-based drug-eluting stents. So far, only polymeric …
conventional, non-absorbable metal-based drug-eluting stents. So far, only polymeric …
Clinical impact of OCT findings during PCI: the CLI-OPCI II study
Objectives The goal of this study was to assess the clinical impact of optical coherence
tomography (OCT) findings during percutaneous coronary intervention (PCI). Background …
tomography (OCT) findings during percutaneous coronary intervention (PCI). Background …
Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective …
M Haude, R Erbel, P Erne, S Verheye, H Degen… - The Lancet, 2013 - thelancet.com
Background Bioabsorbable vascular scaffolds were developed to overcome limitations of
permanent bare-metal or drug-eluting coronary stents—ie, stent thrombosis (despite …
permanent bare-metal or drug-eluting coronary stents—ie, stent thrombosis (despite …
Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization?
Y Onuma, PW Serruys - Circulation, 2011 - Am Heart Assoc
Gruntzig in 1977 was a huge leap forward in cardiovascular medicine and undoubtedly will
always be remembered as a revolution in the field of revascularization. However, this …
always be remembered as a revolution in the field of revascularization. However, this …
From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?
PW Serruys, HM Garcia-Garcia… - European heart …, 2012 - academic.oup.com
Drug-eluting bioresorbable scaffolds (BRSs) may in the near future change drastically the
landscape of percutaneous coronary revascularization. 1 In 1977, when Andreas Gruentzig …
landscape of percutaneous coronary revascularization. 1 In 1977, when Andreas Gruentzig …
Comparison of everolimus-and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds
S Puricel, D Arroyo, N Corpataux, G Baeriswyl… - Journal of the American …, 2015 - jacc.org
Background: The first CE-approved bioresorbable vascular scaffold (BVS) is effective at
treating simple lesions and stable coronary artery disease, but it has yet to be assessed …
treating simple lesions and stable coronary artery disease, but it has yet to be assessed …
Scaffold thrombosis after percutaneous coronary intervention with ABSORB bioresorbable vascular scaffold: a systematic review and meta-analysis
MJ Lipinski, RO Escarcega, NC Baker, HA Benn… - JACC: Cardiovascular …, 2016 - jacc.org
Objectives: The aim of this study was to determine the risk of scaffold thrombosis (ST) after
percutaneous coronary intervention (PCI) with placement of an ABSORB bioresorbable …
percutaneous coronary intervention (PCI) with placement of an ABSORB bioresorbable …